Joshua Kushner Purchases 276,040 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner purchased 276,040 shares of Oscar Health stock in a transaction dated Monday, November 11th. The stock was bought at an average price of $13.58 per share, with a total value of $3,748,623.20. Following the acquisition, the insider now directly owns 5,031,262 shares of the company’s stock, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Joshua Kushner also recently made the following trade(s):

• On Wednesday, November 13th, Joshua Kushner bought 358,619 shares of Oscar Health stock. The stock was purchased at an average price of $13.74 per share, for a total transaction of $4,927,425.06.

Oscar Health Stock Performance

Shares of OSCR stock opened at $15.45 on Friday. The company has a market capitalization of $3.74 billion, a price-to-earnings ratio of -251.12, a PEG ratio of 12.49 and a beta of 1.67. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.91 and a current ratio of 0.73. Oscar Health, Inc. has a 52 week low of $6.93 and a 52 week high of $23.79. The company has a 50-day simple moving average of $18.28 and a 200 day simple moving average of $18.30.

Oscar Health (NYSE:OSCR) last posted its earnings results on Thursday, November 7th. The company reported ($0.22) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to analyst estimates of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. Oscar Health’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.29) EPS. On average, sell-side analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Analyst Upgrades and Downgrades

OSCR has been the topic of several recent research reports. Piper Sandler reiterated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group assumed coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock. Finally, Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.93.

Institutional Investors Weigh In On Oscar Health

Hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in Oscar Health by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after purchasing an additional 337,850 shares during the period. Price T Rowe Associates Inc. MD raised its position in shares of Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares in the last quarter. Renaissance Technologies LLC grew its position in Oscar Health by 31.7% during the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after buying an additional 934,600 shares in the last quarter. First Light Asset Management LLC increased its stake in Oscar Health by 117.3% during the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after acquiring an additional 1,134,919 shares during the period. Finally, Assenagon Asset Management S.A. raised its holdings in Oscar Health by 32.9% in the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after acquiring an additional 507,009 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.